-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Underweight on Moderna, Raises Price Target to $102

Benzinga·11/17/2026 18:39:16
Listen to the news
JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and raises the price target from $77 to $102.